U.S. market to reach USD 156.90M and Europe USD 96.02M by 2035, driven by pharma R&D, biomarker development and multiplexed imaging.
U.S. market to reach USD 156.90M and Europe USD 96.02M by 2035, driven by pharma R&D, biomarker development and multiplexed imaging.